166 related articles for article (PubMed ID: 25632353)
1. Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis.
Nielung L; Christensen R; Danneskiold-Samsøe B; Bliddal H; Holm CC; Ellegaard K; Slott Jensen H; Bartels EM
Arthritis; 2015; 2015():401690. PubMed ID: 25632353
[TBL] [Abstract][Full Text] [Related]
2. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
4. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.
Tamhane A; Redden DT; McGwin G; Brown EE; Westfall AO; Reynolds RJ; Hughes LB; Conn DL; Callahan LF; Jonas BL; Smith EA; Brasington RD; Moreland LW; Bridges SL
J Rheumatol; 2013 Nov; 40(11):1812-22. PubMed ID: 23950187
[TBL] [Abstract][Full Text] [Related]
6. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
7. DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable.
Fleischmann RM; van der Heijde D; Gardiner PV; Szumski A; Marshall L; Bananis E
RMD Open; 2017; 3(1):e000382. PubMed ID: 28255449
[TBL] [Abstract][Full Text] [Related]
8. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
Chandrashekara S; Priyanka BU
Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
[TBL] [Abstract][Full Text] [Related]
9. DAS28-ESR and DAS28-CRP - are they Interchangeable in Measuring the Activity of Rheumatoid Arthritis in Response to Treatment with Biological Agents?
Shivacheva TK
Folia Med (Plovdiv); 2020 Mar; 62(1):46-51. PubMed ID: 32337896
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
11. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.
Siemons L; Vonkeman HE; ten Klooster PM; van Riel PL; van de Laar MA
Clin Rheumatol; 2014 Jun; 33(6):783-9. PubMed ID: 24562719
[TBL] [Abstract][Full Text] [Related]
12. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM
Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871
[TBL] [Abstract][Full Text] [Related]
13. DAS28-CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28-ESR in Rheumatoid Arthritis.
Greenmyer JR; Stacy JM; Sahmoun AE; Beal JR; Diri E
ACR Open Rheumatol; 2020 Sep; 2(9):507-511. PubMed ID: 32862564
[TBL] [Abstract][Full Text] [Related]
14. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
15. Chinese registry of rheumatoid arthritis: IV. Correlation and consistency of rheumatoid arthritis disease activity indices in China.
Song X; Wang YH; Li MT; Duan XW; Li HB; Zeng XF;
Chin Med J (Engl); 2021 Jun; 134(12):1465-1470. PubMed ID: 34134125
[TBL] [Abstract][Full Text] [Related]
16. Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.
Balogh E; Madruga Dias J; Orr C; Mullan R; Harty L; FitzGerald O; Gallagher P; Molloy M; O'Flynn E; Kelly A; Minnock P; O'Neill M; Moore L; Murray M; Fearon U; Veale DJ
Arthritis Res Ther; 2013 Dec; 15(6):R221. PubMed ID: 24365061
[TBL] [Abstract][Full Text] [Related]
17. Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis.
Kim SK; Choe JY
Arch Rheumatol; 2018 Jun; 33(2):143-149. PubMed ID: 30207575
[TBL] [Abstract][Full Text] [Related]
18. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
[TBL] [Abstract][Full Text] [Related]
19. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study.
Cai YM; Li R; Ye H; He J; Sun XL; Jin JY; Liu JJ; Gan YZ; You XJ; Xu J; Shi LJ; Cheng G; Wang QW; Li ZG
Chin Med J (Engl); 2020 Jun; 133(12):1397-1403. PubMed ID: 32496302
[TBL] [Abstract][Full Text] [Related]
20. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
